T. M. Kim

Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial

Se‐Hoon Lee, Jake June-Koo Lee, Myung‐Ju Ahn et al. · Annals of Oncology · 2016 · 248 citations

Pretreated Patients, Medicine, Bronchial Neoplasm +6

Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study

Jake June-Koo Lee, Jong Yeon Shin, Su‐Hyeon Kim et al. · Annals of Oncology · 2013 · 125 citations · Full text

Medicine, Growth Factor Receptor, Receptor Tyrosine Kinase +9

Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma

J.-L. Lee, Jin‐Hee Ahn, Ho Yeong Lim et al. · Annals of Oncology · 2012 · 100 citations · Full text

Urology, Genitourinary Cancer, Medicine +3

Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma

Youngil Koh, Ho Yeong Lim, Jae Hun Ahn et al. · Annals of Oncology · 2012 · 86 citations · Full text

Urology, Surgical Oncology, Phase Ii Trial +6

A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma

Chul‐Kee Park, Ji-Eun Kim, Do‐Hyun Nam et al. · Neuro-Oncology · 2013 · 78 citations · Full text